Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Abiomed Inc (ABMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 13,546,138
  • Shares Outstanding, K 44,280
  • Annual Sales, $ 445,300 K
  • Annual Income, $ 52,120 K
  • 36-Month Beta 0.17
  • Price/Sales 25.59
  • Price/Cash Flow 228.80
  • Price/Book 21.42

Price Performance

See More
Period Period Low Period High Performance
1-Month
274.23 +11.56%
on 04/03/18
309.28 -1.09%
on 04/18/18
+11.91 (+4.05%)
since 03/20/18
3-Month
219.13 +39.61%
on 02/09/18
309.28 -1.09%
on 04/18/18
+77.63 (+34.01%)
since 01/19/18
52-Week
123.60 +147.51%
on 05/04/17
309.28 -1.09%
on 04/18/18
+180.71 (+144.33%)
since 04/20/17

Most Recent Stories

More News
Abiomed Inc Shares Up 23.8% Since SmarTrend's Buy Recommendation (ABMD)

SmarTrend identified an Uptrend for Abiomed Inc (NASDAQ:ABMD) on February 14th, 2018 at $246.40. In approximately 2 months, Abiomed Inc has returned 23.78% as of today's recent price of $304.99.

ABMD : 305.92 (-0.17%)
Here's Why You Should Invest in Integer Holdings Right Now

Integer Holdings' (ITGR) unswerving focus on customer relationship, cost reduction and burgeoning financial performance are key catalysts.

ITGR : 55.35 (-1.95%)
ABMD : 305.92 (-0.17%)
MYGN : 28.90 (-0.48%)
BIO : 260.68 (-0.60%)
Edwards Lifesciences' (EW) THVT Likely to Drive Q1 Earnings

Edwards Lifesciences (EW) is expected to gain from strength in THVT on continued therapy adoption across all geographies in Q1.

EW : 137.09 (-1.06%)
ABMD : 305.92 (-0.17%)
BIO : 260.68 (-0.60%)
LH : 165.17 (-1.84%)
Intuitive Surgical (ISRG) Beats on Q1 Earnings & Revenues

Intuitive Surgical's (ISRG) da Vinci platform drives growth in Q1, international sales rise.

ABMD : 305.92 (-0.17%)
MYGN : 28.90 (-0.48%)
BIO : 260.68 (-0.60%)
ISRG : 456.27 (-1.39%)
Here's Why You Should Hold on to Cerner (CERN) Stock for Now

Cerner (CERN) gains ground on solid EHR platform, stiff competition raises concern.

CERN : 58.23 (-1.17%)
ABMD : 305.92 (-0.17%)
MYGN : 28.90 (-0.48%)
BIO : 260.68 (-0.60%)
Abiomed Inc Rises 2.20% on Heavy Volume: Watch For Potential Pullback

Abiomed Inc (NASDAQ:ABMD) traded in a range yesterday that spanned from a low of $294.28 to a high of $303.53. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high of...

ABMD : 305.92 (-0.17%)
Can MedSurg Business Aid Boston Scientific (BSX) Q1 Earnings?

Boston Scientific's (BSX) MedSurg business is likely to deliver an encouraging show in Q1 on the back of a strong endoscopy, driven by biliary, hemostasis, EndoChoice and Symetis buyouts.

ABMD : 305.92 (-0.17%)
BSX : 28.84 (-0.17%)
MYGN : 28.90 (-0.48%)
BIO : 260.68 (-0.60%)
Can Neurotechnology & Spine Drive Stryker (SYK) Q1 Earnings?

Stryker's (SYK) Neurotech business goes strong, VEXIM buyout likely to boost segment.

SYK : 164.25 (+0.43%)
ABMD : 305.92 (-0.17%)
MYGN : 28.90 (-0.48%)
BIO : 260.68 (-0.60%)
Can Solid Medical Devices Drive Abbott's (ABT) Q1 Earnings?

Abbott (ABT) poised to gain on continued growth in Medical devices business in Q1.

ABT : 59.19 (-1.15%)
ABMD : 305.92 (-0.17%)
MYGN : 28.90 (-0.48%)
BIO : 260.68 (-0.60%)
Medical Instrument Stocks Head-to-Head: Abiomed vs. STERIS

Here we take a look at the fundamentals of Abiomed (ABMD) and STERIS (STE) to determine which stock is a better pick in the Medical Instruments space.

EW : 137.09 (-1.06%)
STE : 96.04 (-0.19%)
ABMD : 305.92 (-0.17%)
ABAX : 72.72 (-0.79%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Abiomed, Inc. is a provider of mechanical circulatory support devices and offers a continuum of care to heart failure patients. The Company develops, manufactures and markets proprietary products that are designed to enable the heart to rest, heal and recover by improving blood flow and/or performing...

See More

Key Turning Points

2nd Resistance Point 309.66
1st Resistance Point 307.79
Last Price 305.92
1st Support Level 303.38
2nd Support Level 300.84

See More

52-Week High 309.28
Last Price 305.92
Fibonacci 61.8% 238.35
Fibonacci 50% 216.44
Fibonacci 38.2% 194.53
52-Week Low 123.60

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar